National Insurance Contributions: Healthcare

John Lamont Excerpts

Thursday 14th November 2024 Commons Chamber

[Karin Smyth]

Well, I do agree with my hon. Friend. As I have said, when I became a Member of Parliament in 2015, I remember very clearly the absolute shock that I felt when the Conservatives immediately announced that they were not going to meet the commitment that they had made to implement the Care Act 2014 at that time, and we are still playing catch-up on that issue.

[John Lamont (Berwickshire, Roxburgh and Selkirk) (Con)]

Doctors from Duns, Galashiels, Selkirk, Kelso and across the Scottish Borders have contacted me about the impact that this national insurance hike will have on their practices. They tell me that the decision will be a huge retrograde step for primary care, will have a huge financial impact on their practices, and will undermine access to primary and patient care. Why have the Labour Government made this choice to hammer local doctors?

[Karin Smyth]

As I have said, we have made a commitment to general practice and primary care by releasing extra GPs into the system. We recognise the situation in which GPs find themselves. I know this because I worked with GP practices in my previous career. We need those practices to be the foundation of our neighbourhood services, which is why we will talk in the normal process about the allocations over the next few months as part of the contract.

NHS Dentistry

John Lamont Excerpts

Thursday 20th October 2022 Commons Chamber

[John Lamont (Berwickshire, Roxburgh and Selkirk) (Con)]

The dental services that my constituents use are the responsibility of the Scottish Government in Edinburgh. My comments will focus on the challenges that we face in Scotland in accessing NHS dentistry.

I begin by thanking the dentists in my constituency, who are doing the best they can and working hard to provide essential services for people across the Scottish Borders. There is no doubt, however, that dentists, dental staff and medical professionals are hamstrung in their ability to meet the needs of every constituent because of the lack of support and help they get from the Scottish National party Government in Edinburgh. Although the SNP would like to pretend otherwise to deflect from their failures, Scotland’s NHS is devolved and is the sole responsibility of the SNP Government in Holyrood.

However, instead of focusing on improving waiting times in Scotland’s NHS for dentists and GPs, the SNP Government are again distracted by their endless obsession. They are again banging on about another referendum when people across the Scottish Borders and across Scotland want the focus to be on their everyday needs. Whether we are talking about nationalists or Unionists, the SNP or Scottish Conservatives, would it not be better for everybody if the Scottish Government’s No. 1 priority was to deliver better public services for the people across Scotland? We know that that will not happen with the SNP. Its first, last and only real priority is another referendum to break up the United Kingdom, as it proved again this week.

If SNP Members were here to represent the SNP, I would tell them that those who talk about division all the time are letting down my constituents. They fail my constituents across the Scottish Borders every day and every week. One constituent wrote to me recently about the lack of emergency care on weekends. While in pain and clearly in need of help, they were told to go to the shops and buy a temporary filling repair. If any Members were here to represent the SNP, I would ask them to tell me how that person is helped by another independence referendum when the SNP Government are failing to deliver for them right now.

Another patient wrote to me about the closure of dental services in Berwick-upon-Tweed just across the border. As a result of the lack of local services, she was not offered a spot for treatment nearby in the Scottish Borders. She was told that the only dentist available was miles and miles away. It was far too far away for her to travel there. That is another direct result of the SNP Government in Edinburgh not understanding the needs of local people in the Scottish Borders and rural areas across Scotland.

My constituents should be able to see a dentist in person when they need help. Local people in the Scottish Borders deserve the same access to the NHS that people in the rest of Scotland and the United Kingdom receive. Despite the best efforts of healthcare staff, that is simply not happening. Too often, the needs of people in the Scottish Borders have been overlooked by the SNP Government in Holyrood. So I would ask SNP Members, if they were here—I add again, for the Hansard record, that they are not—how the flimsy economic plan for independence revealed this week helps my constituents get access to the health services they need.

Another constituent wrote to me about her two-year-old son, who has not been able to see a dentist since he was born. The next time the SNP is making big, overblown promises about the future of Scotland, why does it not try delivering for future generations of Scottish people by doing the day job and providing the basic services that people need?

The SNP Health Secretary, Humza Yousaf, is completely failing to deliver for Scotland. Recent statistics revealed that one in four people in Scotland have tried and failed to get a dental appointment over the past year. In rural areas, the problem is even more acute. Access to the NHS is a big problem for local people in the Scottish Borders. It is time that the SNP recognised that, accepted responsibility for its failures and got a grip on the situation. To conclude, will the UK Health Minister engage with colleagues in the Scottish Government to ensure that my constituents are given the best support possible to access the dental services they deserve?

Motor Neurone Disease

John Lamont Excerpts

Thursday 20th October 2022 Commons Chamber

[John Lamont (Berwickshire, Roxburgh and Selkirk) (Con)]

Motor neurone disease is an incredibly cruel and scary illness. It can strike anyone at any time. It can knock young and healthy people down in their prime. What makes this disease so frightening is the fear of the unknown. There is no cure for it. We do not know why it occurs. All that makes it even more remarkable that so many brave people suffering from MND find the courage to speak out candidly and publicly about their condition. I pay tribute to all those who campaign so passionately to find a cure, especially those who suffer from the awful effects that the disease causes to them personally. In this debate, however, I want to highlight one particular inspirational person who suffers from MND, and whom I am proud to say I represent as his Member of Parliament in the Scottish Borders.

Long before he was told he had MND six years ago, my constituent Doddie Weir was a hero to people across the Borders and all over Scotland, but he has become even more of a hero since his diagnosis. In his playing days he was a tartan colossus, a giant of Scottish sport. He was a big character on the pitch at Murrayfield—once famously described by the Scottish commentator Bill McLaren as being

“on the charge like a mad giraffe”.

However, Doddie is an even bigger character off the park. He lives his life to the fullest, even now. His positive energy is infectious. When anyone has been around Doddie, they are happier for it. He fought hard every time he took to the rugby pitch, and he continues to fight, even harder, on his mission to find a cure for MND.

I cannot say enough how much I admire Doddie for remaining relentlessly positive, no matter what life throws at him. Receiving an honorary degree earlier this year in Scotland, he said:

“Six years later, still fighting, still pushing for that cure, and still winning with every new day. If things don’t go your way, don’t give up. Instead, use your tremendous energy and brains, try again. There’s always a way round, another way to achieve your goals—find it.”

We owe it to Doddie and everyone in his position to keep fighting for a cure, and we owe it to Doddie to listen closely to his frank assessment of the Government’s funding for research. He said recently that the Government needed to act with more urgency. He said that the fight for a cure was

“definitely getting better but the government has not given MND the money they promised.”

He also said:

“The current process for accessing the money is just not delivering for the MND community. It needs to be streamlined or the professors will spend their valuable time writing multiple applications instead of tackling MND.”

Last year, the Government made a generous and welcome commitment to invest £50 million in motor neurone disease research. I was incredibly proud to play my part in pushing for that funding towards a cure for the devastating disease. That victory, won overwhelmingly by Doddie’s relentless campaigning, was a wonderful display of compassionate government; it is one of the finest actions that this Conservative Government have taken.

But just as Doddie never stopped on the pitch and continues never to stop loving life, we must keep pushing to make sure that this vital funding reaches the frontline faster. Today I want to urge the Government and the Minister to listen to Doddie and do what he asks—not just for his sake, but for every patient in need of some hope. I urge them to provide more resources for MND research, to improve the process and to deliver on our promises. Let us continue to play our part in finding a cure for this awful disease.

Childhood Cancer Outcomes

John Lamont Excerpts

Tuesday 26th April 2022 Commons Chamber

[Dame Caroline Dinenage]

The right hon. Gentleman is absolutely right. I shall talk about research in a moment, but childhood cancer research is currently the Cinderella of cancer research and we need to do much more to address that.

Once a child has been diagnosed, the gruelling process of treating the cancer begins. Between 1997 and 2018, only 18 new drugs were approved for 22 paediatric oncology indications, and they were generally for quite specific or relapse cases. That means many children are often given the same treatments as adults—incredibly aggressive chemotherapies and radiotherapies—and in many cases children’s treatments have not changed for decades. Even if the cancer is beaten, the child’s body is often so ravaged by the treatment as to leave long-term impacts from which they may never recover.

[John Lamont (Berwickshire, Roxburgh and Selkirk) (Con)]

My hon. Friend is speaking remarkably passionately about this important issue, about which many of my constituents have been in touch with me. They include Julie and her son George, and Leah and her son Toby—both children are suffering and living with cancer. Does my hon. Friend agree that much more needs to be done when children finish the course of treatment to support not only the child but the family, in terms of their recovery from the physical and emotional impact of the treatment?

[Dame Caroline Dinenage]

My hon. Friend makes an excellent point: there is such a huge impact on families who support a child through cancer and we need to look at how we support them in the round.

I have heard from parents of children who are known as cancer free—so they are probably counted as a success statistically—yet some of them are still in hospital because of the disastrous impact of the treatment itself. Very many survivors are left with long-term hormone deficiencies, some of which are life threatening. Survivors can also experience neurological, behavioural, cognitive and visual impairment. The St Jude Hospital in the United States takes an annual survey of former patients. By the age of 50, they all—100% of them—have life-altering health issues, from fertility issues to severe neuro-disability. I would love to know whether similar surveys happen here and whether the conclusions are the same.

As other Members have said, it is vital to find better treatments specifically for children, which means better research is vital. Children’s cancer is fundamentally different from adult cancer in that so much of it is developmental rather than environmental. The good news is that progress is within our reach—there is so much potential in immunotherapy and genomics—and the even better news is that the UK has a fantastic research community and the most comprehensive database of childhood cancer genomes anywhere in the world. The bad news is that paediatric oncology research is the absolute backwater of cancer sciences. It does not have the focus, the money, the public relations or the prestige of other forms of research. Until there is a concerted effort to change that, children like Sophie will be failed.

I expect the Minister to tell me today that great progress has been made on the cancer survival rate among children. Seventy years ago, children simply did not recover or survive a cancer diagnosis; now around 80% do. But the figures belie the fact that for many cancers, including the rhabdomyosarcoma that killed Sophie, the survival rate is as low as 20%. For another cancer, DIPG—diffuse intrinsic pontine glioma, which is a form of brain tumour—the survival rate is 0%. It is literally a death sentence. Can you imagine being that child? Can you imagine being that parent?

There is no doubt that research investment drives survival rates. Since 1960, the survival rate for childhood leukaemia has improved from 10% to 80%. By contrast, only two multinational clinical trials have ever taken place for rhabdomyosarcoma. With only 60 cases diagnosed in the UK per year, there is very little scientific evidence or appetite to develop and complete clinical trials. It is of no interest to big pharma. So we need to look much more imaginatively at how the National Institute for Health and Care Research can encourage more research in such types of cancer.

We also need to look at how new treatments can be brought forward much more quickly. I met Kevin and Karen, who lost their son Christopher just days before his sixth birthday from an aggressive form of brain tumour. They raised concerns about the EU paediatric regulations, which they feel are outdated and do not reflect the latest technological advances. Now that we have left the EU, we have the opportunity to produce new legislation that will incentivise world-leading pharmaceutical products, especially for children, and we need to take that opportunity.

Today, I ask the Minister to start a children’s cancer mission. We have seen from the incredible work on brain cancer inspired by our much-loved former colleague Tessa Jowell how much progress can be made when we are galvanised to bring together the best of Governments, charities, research, academics, medical and science into centres of excellence.

Oral Answers to Questions

John Lamont Excerpts

Tuesday 18th January 2022 Commons Chamber

[Sajid Javid]

The hon. Gentleman is right about the importance of helping the whole world to acquire these life-saving vaccines. That is why the UK can be proud of the more than 30 million vaccines that it has delivered to developing countries already. We will meet our commitment to increase that to 100 million by June, but we do not agree with the suggestion about the TRIPS waiver, because it will make future access to life-saving vaccines much more difficult.

[John Lamont (Berwickshire, Roxburgh and Selkirk) (Con)]

T6. I was delighted by the recent announcement of £50 million for motor neurone disease research, which my constituent Doddie Weir campaigned for tirelessly. Will the Secretary of State update the House on the steps being taken to allocate those funds, and to ensure that is done as quickly as possible, as time is of the essence for MND sufferers?

[Sajid Javid]

My hon. Friend is right to raise that point, and I commend him on the fantastic work that he has done in leading this campaign. We were delighted to announce £50 million of funding for MND research. That will support a new MND research unit, which has already started work to co-ordinate research applications, and a new MND partnership, which will be formed to pool expertise across the research community.

Covid-19 Update

John Lamont Excerpts

Friday 26th November 2021 Commons Chamber

[Sajid Javid]

I very much agree with every word the right hon. Gentleman says, especially about surplus vaccines. That is exactly what we have done: whenever we have identified vaccines we may not need, we have offered them either bilaterally or through the COVID-19 Vaccines Global Access, or COVAX, programme. We will continue to play our role but, importantly, we will also continue to urge our international partners to do all they can as well.

[John Lamont (Berwickshire, Roxburgh and Selkirk) (Con)]

I commend the Government for the speed with which they have taken this decision and I welcome the Scottish Government’s following suit, because in the past there has been concern about the lack of consistency across the UK. Does the Health Secretary agree that this is a useful reminder that the pandemic is still with us and we all have a responsibility to get vaccinated, which includes getting the booster?

[Sajid Javid]

First, I can tell my hon. Friend that there has been excellent co-ordination across the UK on this matter. As I mentioned earlier, Scotland and all parts of the UK will be aligning with what I have announced. The booster programme, as I say, could not be more important. The very latest figures are that 28.5% of the UK population over the age of 12 has been boosted, far and away more than any other country in Europe and, I think, second only to the United States, but that is still not enough. We need everyone to come forward, and if there are people out there listening and wondering what they can do, the single most important thing they can do, if they are eligible for a booster, is to go and get it. Go out this weekend and make it your booster weekend.

Endometriosis and Polycystic Ovary Syndrome

John Lamont Excerpts

Monday 1st November 2021 Westminster Hall

[John Lamont (Berwickshire, Roxburgh and Selkirk) (Con)]

It is a pleasure to serve with you in the Chair this afternoon, Mr Mundell. I associate myself with your remarks and those of others during this debate about our colleague Sir David Amess, and my thoughts and prayers are with his wife and kids at this very difficult time.

I am pleased to participate in this debate today in order to recognise publicly the great work that Endo Borders, set up by Tao McCready—who lives in my constituency—is doing on behalf of women who suffer from this terrible condition. Mr Mundell, as the other Member of Parliament for the Scottish borders, I know that you are familiar with that group and the important work it is doing in our area. Tao was diagnosed with endometriosis in 2017, following multiple misdiagnoses, and went on to set up Endo Borders in 2019, giving up a career to focus on supporting the local community and raising awareness of the condition. Not only is it a fantastic group for women in the Scottish borders; it also reaches out to women across the country who are suffering from endometriosis. I had the privilege of attending a recent meeting of Endo Borders, and was really impressed by the courage of the women who were sharing their stories.

Endo affects one in 10 women in the United Kingdom, but despite its prevalence not much is known about it and relatively few people have heard of it—I certainly had not until I met that group. There is currently no cure for endo, and its exact cause is unknown. In Scotland, the average diagnosis time is eight years. The difficulty is that there is not a specific list of symptoms for endo, as the condition presents differently in different women. Research by Endometriosis UK found that 54% of the UK population were unaware of the condition, and 45% of women were unaware of its symptoms. To put that in perspective, a far greater proportion of the population has heard of diabetes, and endometriosis affects a similar number of people.

What can be done to help women suffering from this condition, particularly those who live in my constituency in Scotland? First, clearly awareness about endometriosis needs to be raised, and it is crucial to ensure that Scotland comes into line with England by providing menstrual health education at school. Without learning about the menstrual cycle at a young age, conditions such as endo will continue to go unrecognised, marginalised and misunderstood.

Secondly, although there are three specialist centres for endo in Scotland, the all-party parliamentary group on endometriosis found that because those services have been commissioned at a local level, it can sometimes be difficult to get referrals to the different health board areas in which those services are based. It cannot just be a postcode lottery. My colleague Rachael Hamilton MSP recently called on the Scottish Government to present a credible plan for how to reduce their own waiting time target for diagnosing endometriosis from eight years to less than one year, and I eagerly await the publication of that plan.

Finally, I am absolutely clear that more can and should be done to improve research into this condition that affects so many women and the way they live their daily lives. I therefore support calls to ensure that funding is directed towards new research into the diagnosis and treatment of this terrible illness, ultimately focusing on a cure.

To conclude, I thank the petitioners for securing this important debate, and the team at Endo Borders for the invaluable work they do to support women suffering from this terrible condition.

[David Mundell (in the Chair)]

I share your praise for Tao McCready and the work of Endo Borders.

Menopause (Support and Services) Bill

John Lamont Excerpts

2nd reading
Friday 29th October 2021 Commons Chamber

[Carolyn Harris]

Thank you, Madam Deputy Speaker. May I suggest that my hon. Friend and I have a conversation outside the Chamber, where we can expand on what she is seeking to establish?

As women reach this stage in their lives, understanding their own bodies and having support in all areas of their lives is crucial, but it is clear that we have a long way to go. That is why the Bill calls on the Secretary of State to lay before Parliament a United Kingdom, cross-party, cross-Government strategy on menopause support and services that will incorporate all the areas I have spoken about.

[John Lamont (Berwickshire, Roxburgh and Selkirk) (Con)]

I congratulate the hon. Lady on all her work on the Bill. My question is about the UK-wide aspect. Clause 1 applies only to England—prescriptions are free in Scotland—but clause 2 applies across the entirety of the United Kingdom. There is a duty to consult Scottish Ministers. If the policy area is devolved to the Scottish Parliament, how will those discussions work in practice? What would happen if Scottish Ministers did not agree with the strategy agreed by the UK Minister?

[Carolyn Harris]

I am going to leave that to the Minister to worry about. I am sure that the Scottish Government do not want me telling them what to do. I would be happy to have a go. If only I was on the Government Benches, then I would get it sorted.

I am not just asking the Secretary of State to do this. I want to work with him, his Ministers and colleagues from across the House to build a taskforce that will take on these issues and find the solutions, because I truly believe that, working together, we can change this—even in Scotland, if necessary.

We also desperately need to look at prescription charges for HRT in England and at what we can do to ensure that the cost is not a barrier to women accessing it. The menopause does not discriminate, so the cost to treat it should not either. There are women struggling to find almost £20 a month, and that just is not right when it is a time in life that women will reach. There is no avoiding the menopause for half the population. Most women will spend at least a third of their lives perimenopausal, post-menopausal or—the joy—menopausal. We must ensure that those women who need it are not denied HRT because of financial restraints.

Cervical Screening

John Lamont Excerpts

Monday 19th July 2021 Westminster Hall

[John Lamont (Berwickshire, Roxburgh and Selkirk) (Con)]

It is a pleasure to serve with you in the Chair, Mr Pritchard.

I am pleased to speak in today’s important date, which has attracted so much support from my constituents in the Scottish borders, with almost 3,000 signatures coming from Berwickshire, Roxburgh and Selkirk—the highest number across the United Kingdom. This can be explained by the fact that the petition was launched by borderer Andrew Mathewson, who lives in Kelso, in my constituency. As we have heard, Andrew tragically lost his wife Fiona, mother of Ivy and Harry, when she died after battling cervical cancer for 17 months, aged just 30.

I have met Andrew, and I admire the way that he has campaigned tirelessly for cervical cancer screening, in memory of Fiona, and dedicated his work to ensure that other families do not go through what they had to. Fiona’s story is close to the hearts of many people in the Scottish borders who know the Mathewsons, and indeed many people far beyond and across the country, with over 146,000 signatures recorded in total for the petition.

The NHS and this policy area are devolved to the Scottish Parliament, and my comments will have a distinctive Scottish slant. Around 850 women die from cervical cancer each year in the UK. Sadly, that is more than two women every day. Yet cervical cancer is one of the most preventable cancers for two key reasons. First, cervical screening tests check for abnormal changes in sample cells from the cervix. Cervical screening is not a test for cancer, but early detection allows action to be taken to prevent cervical cancer from developing.

Second, the HPV jab is on offer to every child between 12 and 14 in Scotland. For girls, it is designed to protect against types of HPV that cause around 70% of all cases of cervical cancer in Scotland. In most people, HPV does not cause harm and the infection clears on its own, but in some cases HPV infection can lead to cell changes that progress into cervical cancer. Taken together, cervical screening and the HPV vaccine mean that cervical cancer can be avoided.

Cancer Research UK has stated that cervical screening is the best protection against cervical cancer, yet in Scotland it is offered far less frequently than in the rest of the UK. In England, Wales and Northern Ireland, women between 25 and 49 are screened every three years, but women in Scotland face a five-year wait between each screening. Over the past year, some women were notified that their waiting time of five years would be extended as NHS Scotland rightly diverted time and resources to tackling covid-19. However, I am pleased that the resumption of cancer services, including cervical screening, are now being treated as a priority by NHS Scotland.

Alarmingly, this transparency from NHS Scotland was not mirrored by the Scottish Government, who failed to reveal that a number of women had developed cervical cancer after being wrongly excluded from the screening programme following a hysterectomy. One of those women tragically died. The SNP Government were made aware of the errors back in a December audit, but waited until the last day before the summer recess to reveal the scale of the problem to the Scottish Parliament.

This debate is not about party political point scoring, but it would be wrong of me not to highlight the concerns of anxious women, their families and the wider public, who were left in the dark by Scottish Ministers who prioritised their political campaign and attempted to avoid scrutiny. These serious errors have affected hundreds of women, with more cases potentially still to be identified.

The crux of this debate on cervical screening is about the opportunity to reduce the number of women who tragically die from cervical cancer. In my closing remarks, I would like to address some ways in which we can reduce this number of preventable deaths. Evidence shows that the women most likely not to attend a cervical screening appointment are those between the ages of 25 and 34. Yet the evidence also indicates that cervical cancer is the most common cancer in women in this age group. Awareness needs to be raised among women. There is a real incentive to ensure that resources are dedicated to this cause, since cervical cancer can be prevented.

One method that has been trialled in London has involved GPs sending text messages about cervical screening appointments, instead of relying on sending letters through the post. Stigma also needs to be addressed: personal barriers such as lack of knowledge about the purpose and benefits of the test, as well as fear and anxiety about the procedure itself, can play a role in women not attending their appointments. Finally, the Scottish Government should listen to the worries of some Scottish women, who say that they are concerned that they would develop cervical cancer within the five years and just would not know about it.

I end by again paying tribute to Andrew Mathewson and his family and friends, who have been at the forefront of this petition and have ensured that we are debating this important issue today. Andrew continues to selflessly battle on behalf of women he does not even know so that fewer families will have to lose a wife, a mother, a sister or a daughter to this cancer.

Motor Neurone Disease (Research)

John Lamont Excerpts

Monday 12th July 2021 Westminster Hall

[John Lamont (Berwickshire, Roxburgh and Selkirk) (Con)]

It is a pleasure, Ms Cummins, to serve with you in the Chair this afternoon.

I am pleased to take part in the debate on this petition, which has attracted so much support from my own constituents in the Scottish borders, with my constituency of Berwickshire, Roxburgh and Selkirk ranking second in the United Kingdom for the number of signatories in a constituency. I imagine that part of the reason for this is that Doddie Weir, founder of the My Name’5 Doddie Foundation, lives in the Scottish Borders. However, Doddie Weir’s impact extends far beyond the Scottish Borders. In fact, the reason we are all here today for this debate is because the petition was launched by Doddie and his foundation.

Doddie is someone I know well, and I can understand why he has persuaded so many people to support his campaign and petition. He has faced his fair share of challenges on the rugby pitch and has a remarkable list of achievements to his name: 61 caps for Scotland; representing the British and Irish Lions; and playing locally for Melrose as well. However, Doddie has said on numerous occasions that the greatest challenge he has faced is off the pitch—battling motor neurone disease.

In June 2017, Doddie revealed that he was suffering from MND, and within months he and his trustees launched a registered charity—My Name’5 Doddie Foundation. The way in which Doddie is driven to champion fellow sufferers and research into this devastating and currently incurable disease is both admirable and inspiring. His selfless work has been vital in raising awareness and generating millions of pounds for such an important cause. Doddie and the foundation have generated huge momentum among individuals, sports clubs and other organisations to raise awareness and vital funding for MND research and support. I was honoured to raise money for the cause by running the London marathon in 2018.

Many other borderers have completed challenges for My Name’5 Doddie Foundation. There are too many to mention in this short contribution, but challenges such as Lions Trek for Doddie and the Coast to Coast in 24 hours come to mind. The Prime Minister also threw his support behind Doddie’s Active Inter-District challenge, which raised more than £1 million.

At the crux of this debate is a devastating disease—a rapidly progressing neurological condition that leaves individuals unable to walk, talk, eat and, ultimately, breathe. One in 300 people develop it in their lifetime, and a third die within a year of receiving their diagnosis. My Name’5 Doddie Foundation provides practical help through grants, and funds research into this terrible disease. It gives considerable sums to the MND Association and MND Scotland to provide support for individuals and their families living with motor neurone disease. Overall, it has raised more than £8 million since 2017. It has granted more than £3 million to medical research projects, and more than £1 million has been given through grants to help sufferers of MND.

In March, when I asked the Prime Minister about funding for MND research in Prime Minister’s questions, I was reassured to hear that the Government have spent £54 million on research over the past five years through the National Institute for Health Research and UK Research and Innovation. I am also glad that the Government are putting in place plans to deliver their 2019 manifesto commitment to double funding for dementia research, which includes MND research. However, it is crucial that we redouble our efforts to consolidate the work that has been done. It is vital that Governments across the UK, the research community and charities work together in the hope that, one day, we can find a cure.

I pay tribute to Doddie, My Name’5 Doddie Foundation, MND Scotland and the MND Association. Those organisations are dedicated to supporting sufferers of MND and their families, and are striving relentlessly to find a cure for this horrible disease.